Log In
BCIQ
Print this Print this
 

lemborexant (E2006)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionDual orexin receptor antagonist
Molecular Target Orexin 1 receptor (OX1R) (HCRTR1) ; Orexin 2 receptor (OX2R) (HCRTR2)
Mechanism of ActionOrexin receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInsomnia
Indication DetailsTreat irregular sleep-wake rhythm disorder (ISWRD); Treat chronic insomnia
Regulatory Designation
PartnerPurdue Pharma L.P.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/31/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today